{"title":"失代偿性肝硬化和大容量穿刺对生存的影响:一项回顾性队列研究","authors":"Karla P. Perez-Lopez, Miriam G. Reyes-Zermeño","doi":"10.1016/j.aohep.2025.101804","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction and Objectives</h3><div>Ascites is the most common complication of cirrhosis. Its presence represents a 40% mortality at 2 years. The objective of this study was to determine survival in patients with decompensated liver cirrhosis due to ascites undergoing large-volume paracentesis.</div></div><div><h3>Materials and Patients</h3><div>A retrospective, cross-sectional, observational, analytical study was conducted. Patients with liver cirrhosis over 18 years of age of both sexes, of any etiology, treated at Centro Médico Nacional 20 de Noviembre between January 2013 and June 2023, who underwent large volume paracentesis, were selected and matched 2:1 with controls who did not require high volume paracentesis, adjusted for disease severity, age, sex, and Child-Pugh stage. Exclusion criteria were pregnancy or lactation, under 18 years of age, and ascites of a different origin than chronic liver disease. The data was extracted from clinical records.</div></div><div><h3>Results</h3><div>A total of 226 patients were analyzed, 61.9% women (n=140) and 38.1% men (n=86). The average age was 64.28 years (SD=13.33). The minimum age was 19 years and maximum was 91 years. The most frequent etiology was hepatic steatosis in 34.07% (n=77), followed by hepatitis C in 19.91% (n=45), alcoholism in 12.38% (n=28), autoimmune hepatitis in 10.17% (n=23). The distribution of patients by Child-Pugh classification was B in 69% (n=156) and C in 31% (n=70). The average MELD-NA score was 16.93 (SD=7.10). The main comorbidities were 36.7% (n=83) type 2 diabetes mellitus, 24.8% (n=56) systemic arterial hypertension, 15% (n=34) chronic kidney disease, and 16.4% (n=37) obesity.</div><div>Out the 226 patients with liver cirrhosis with ascites, 33.2% (n=75) underwent large volume paracentesis while 66.8% (n=151) underwent paracentesis less than 5 liters. The mortality of patients undergoing large volume paracentesis was 32% compared to 20.5% RR 1.55, IC 95% (0.98-2.45) of patients who did not. In bivariate analysis by sex, there were no statistically significant differences in mortality. Stratified analysis by nutritional status with body mass index did not show differences in mortality in patients undergoing large volume paracentesis.</div></div><div><h3>Conclusions</h3><div>No statistically significant differences in mortality were observed between patients undergoing large volume paracentesis and those who did not. It is important to consider that factors other than paracentesis volume may influence patient survival.</div></div>","PeriodicalId":7979,"journal":{"name":"Annals of hepatology","volume":"30 ","pages":"Article 101804"},"PeriodicalIF":3.7000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Impact on survival of decompensated liver cirrhosis and large volume paracentesis: a retrospective cohort\",\"authors\":\"Karla P. Perez-Lopez, Miriam G. Reyes-Zermeño\",\"doi\":\"10.1016/j.aohep.2025.101804\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction and Objectives</h3><div>Ascites is the most common complication of cirrhosis. Its presence represents a 40% mortality at 2 years. The objective of this study was to determine survival in patients with decompensated liver cirrhosis due to ascites undergoing large-volume paracentesis.</div></div><div><h3>Materials and Patients</h3><div>A retrospective, cross-sectional, observational, analytical study was conducted. Patients with liver cirrhosis over 18 years of age of both sexes, of any etiology, treated at Centro Médico Nacional 20 de Noviembre between January 2013 and June 2023, who underwent large volume paracentesis, were selected and matched 2:1 with controls who did not require high volume paracentesis, adjusted for disease severity, age, sex, and Child-Pugh stage. Exclusion criteria were pregnancy or lactation, under 18 years of age, and ascites of a different origin than chronic liver disease. The data was extracted from clinical records.</div></div><div><h3>Results</h3><div>A total of 226 patients were analyzed, 61.9% women (n=140) and 38.1% men (n=86). The average age was 64.28 years (SD=13.33). The minimum age was 19 years and maximum was 91 years. The most frequent etiology was hepatic steatosis in 34.07% (n=77), followed by hepatitis C in 19.91% (n=45), alcoholism in 12.38% (n=28), autoimmune hepatitis in 10.17% (n=23). The distribution of patients by Child-Pugh classification was B in 69% (n=156) and C in 31% (n=70). The average MELD-NA score was 16.93 (SD=7.10). The main comorbidities were 36.7% (n=83) type 2 diabetes mellitus, 24.8% (n=56) systemic arterial hypertension, 15% (n=34) chronic kidney disease, and 16.4% (n=37) obesity.</div><div>Out the 226 patients with liver cirrhosis with ascites, 33.2% (n=75) underwent large volume paracentesis while 66.8% (n=151) underwent paracentesis less than 5 liters. The mortality of patients undergoing large volume paracentesis was 32% compared to 20.5% RR 1.55, IC 95% (0.98-2.45) of patients who did not. In bivariate analysis by sex, there were no statistically significant differences in mortality. Stratified analysis by nutritional status with body mass index did not show differences in mortality in patients undergoing large volume paracentesis.</div></div><div><h3>Conclusions</h3><div>No statistically significant differences in mortality were observed between patients undergoing large volume paracentesis and those who did not. It is important to consider that factors other than paracentesis volume may influence patient survival.</div></div>\",\"PeriodicalId\":7979,\"journal\":{\"name\":\"Annals of hepatology\",\"volume\":\"30 \",\"pages\":\"Article 101804\"},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2025-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of hepatology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1665268125000286\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of hepatology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1665268125000286","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
Impact on survival of decompensated liver cirrhosis and large volume paracentesis: a retrospective cohort
Introduction and Objectives
Ascites is the most common complication of cirrhosis. Its presence represents a 40% mortality at 2 years. The objective of this study was to determine survival in patients with decompensated liver cirrhosis due to ascites undergoing large-volume paracentesis.
Materials and Patients
A retrospective, cross-sectional, observational, analytical study was conducted. Patients with liver cirrhosis over 18 years of age of both sexes, of any etiology, treated at Centro Médico Nacional 20 de Noviembre between January 2013 and June 2023, who underwent large volume paracentesis, were selected and matched 2:1 with controls who did not require high volume paracentesis, adjusted for disease severity, age, sex, and Child-Pugh stage. Exclusion criteria were pregnancy or lactation, under 18 years of age, and ascites of a different origin than chronic liver disease. The data was extracted from clinical records.
Results
A total of 226 patients were analyzed, 61.9% women (n=140) and 38.1% men (n=86). The average age was 64.28 years (SD=13.33). The minimum age was 19 years and maximum was 91 years. The most frequent etiology was hepatic steatosis in 34.07% (n=77), followed by hepatitis C in 19.91% (n=45), alcoholism in 12.38% (n=28), autoimmune hepatitis in 10.17% (n=23). The distribution of patients by Child-Pugh classification was B in 69% (n=156) and C in 31% (n=70). The average MELD-NA score was 16.93 (SD=7.10). The main comorbidities were 36.7% (n=83) type 2 diabetes mellitus, 24.8% (n=56) systemic arterial hypertension, 15% (n=34) chronic kidney disease, and 16.4% (n=37) obesity.
Out the 226 patients with liver cirrhosis with ascites, 33.2% (n=75) underwent large volume paracentesis while 66.8% (n=151) underwent paracentesis less than 5 liters. The mortality of patients undergoing large volume paracentesis was 32% compared to 20.5% RR 1.55, IC 95% (0.98-2.45) of patients who did not. In bivariate analysis by sex, there were no statistically significant differences in mortality. Stratified analysis by nutritional status with body mass index did not show differences in mortality in patients undergoing large volume paracentesis.
Conclusions
No statistically significant differences in mortality were observed between patients undergoing large volume paracentesis and those who did not. It is important to consider that factors other than paracentesis volume may influence patient survival.
期刊介绍:
Annals of Hepatology publishes original research on the biology and diseases of the liver in both humans and experimental models. Contributions may be submitted as regular articles. The journal also publishes concise reviews of both basic and clinical topics.